Abstract:Senecavirus A (SVA)-induced porcine idiopathic vesicular disease has caused huge economic losses worldwide. Glucose metabolism in the host cell is essential for SVA proliferation; however, the impact of the virus on glucose metabolism in host cells and the subsequent effects are still unknown. Here, glycolysis induced by SVA is shown to facilitate virus replication by promoting lactate production, which then attenuates the interaction between the mitochondrial antiviral-signaling protein (MAVS) and retinoic acid-inducible gene I (RIG-I). SVA induces glycolysis in PK-15 cells, as indicated by significantly increased expression of hexokinase 2 (HK2), 6-phosphofructokinase (PFKM), pyruvate kinase M (PKM), phosphoglycerate kinase 1 (PGK1), hypoxia-inducible factor-1 alpha (HIF-1α), and superoxide dismutase-2 (SOD2) in a dose-and replication-dependent manner, and enhanced lactate production, while reducing ATP generation. Overexpression of PKM, PGK1, HIF-1α, and PDK3 in PK-15 cells and high glucose concentrations promote SVA replication, while glycolytic inhibitors decrease it. Inhibition of RLR signaling allowed better replication of SVA by promoting lactate production to attenuate the interaction between MAVS and RIG-I, and regulatory effect of glycolysis on replication of SVA was mainly via RIG-I signaling. SVA infection in mice increased expression of PKM and PGK1 in tissues and serum yields of lactate. Mice treated with high glucose and administered sodium lactate showed elevated lactate levels and better SVA replication, as well as suppressed induction of RIG-I, interferon beta (IFNβ), IFNα, interferon-stimulated gene 15 (ISG15), and interleukin 6 (IL-6). The inhibitory effect on interferons was lower in mice administered sodium oxamate and low glucose compared to the high glucose, indicating that RLR signaling was inhibited by SVA infection through lactate in vitro and in vivo . These results provide a new perspective on the relationship between metabolism and innate immunity of the host in SVA infection, suggesting that glycolysis or lactate may be new targets against the virus. As an emerging virus, SVA induced porcine idiopathic vesicular has caused significant losses worldwide. Existing researches indicates that the ability of SVA to break through the immune barrier of the host mainly due to antagonize type I interferons (IFNs) of the host by the virus and its encoded proteins. However, persistence of the infection which made prevention and control of the disease difficulty, suggesting that other ways may exist for the virus to escape immunological surveillance by the host, and this possibility deserves further exploration. Considering that the energy generated by glucose metabolism of the host cell is needed for virus replication, we attempt to analyze the interaction of SVA and glucose metabolism of host cells and its subsequent effects. In this study, SVA infection induced glycolysis to facilitate its replication by promoting lactate production to inhibits type I IFNs mainly via RIG-I signaling by attenuating the interaction between MAVS and RIG-I was reported. This provides a new perspective on SVA infection from the innate immunity and metabolism of the host and suggests that regulation of glycolysis or targeting lactate production may be new strategies against the virus.

MAVS induces a host cell defense to inhibit CSFV infection

Classical swine fever virus NS4B protein interacts with MAVS and inhibits IL-8 expression in PAMs

Classical Swine Fever Virus Infection and Its NS4A Protein Expression Induce IL-8 Production through MAVS Signaling Pathway in Swine Umbilical Vein Endothelial Cells

MicroRNA-33/33* Inhibit the Activation of MAVS Through AMPK in Antiviral Innate Immunity

Uncovering the Interaction between TRAF1 and MAVS in the RIG-I Pathway to Enhance the Upregulation of IRF1/ISG15 during Classical Swine Fever Virus Infection

Induction of autophagy and suppression of type I IFN secretion by CSFV

N-terminal Domain of Classical Swine Fever Virus Npro Induces Proteasomal Degradation of Specificity Protein 1 with Reduced HDAC1 Expression to Evade from Innate Immune Responses.

Influenza M2 protein regulates MAVS-mediated signaling pathway through interacting with MAVS and increasing ROS production

Large yellow croaker (Larimichthys crocea) mitofusin 2 inhibits type I IFN responses by degrading MAVS via enhanced K48-linked ubiquitination

Mammalian orthoreovirus capsid protein σ3 antagonizes RLR-mediated antiviral responses by degrading MAVS

CSFV induced mitochondrial fission and mitophagy to inhibit apoptosis

Classical Swine Fever Virus Non-Structural Proteins Modulate Toll-like Receptor Signaling Pathways in Porcine Monocyte-Derived Macrophages.

MAVS signaling shapes microglia responses to neurotropic virus infection

Bat MAVS Involved in Antiviral Innate Immunity Via Regulating IFN-beta Production.

Porcine reproductive and respiratory syndrome virus infection induces microRNA novel-216 production to facilitate viral-replication by targeting MAVS 3´UTR

Mitochondrial Antiviral Signaling Adaptor Mediated Apoptosis in H3n2 Swine Influenza Virus Infection is Inhibited by Viral Protein Ns1 in Vitro

Mfn2 is responsible for inhibition of the RIG-I/IRF7 pathway and activation of NLRP3 inflammasome in Seneca Valley virus-infected PK-15 cells to promote viral replication

Porcine Reproductive and Respiratory Syndrome Virus 3C Protease Cleaves the Mitochondrial Antiviral Signalling Complex to Antagonize IFN-β Expression.

Absence of Autophagy Promotes Apoptosis by Modulating the ROS-dependent RLR Signaling Pathway in Classical Swine Fever Virus-Infected Cells

Negative regulation of MAVS-mediated innate immune response by ASC

Senecavirus A-induced glycolysis facilitates virus replication by promoting lactate production that attenuates the interaction between MAVS and RIG-I